Aerovate Therapeutics, Inc. (AVTE) Social Stream
AEROVATE THERAPEUTICS INC (AVTE) Price Targets From Analysts
Use the tables below to see what analysts covering AEROVATE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-16 | 5 | $30 | $21 | $24.666 | $20.62 | 19.62% |
| 2022-05-17 | 3 | $24 | $21 | $22.666 | $20.62 | 9.92% |
| 2022-08-17 | 3 | $32 | $21 | $25.666 | $20.62 | 24.47% |
| 2022-08-22 | 4 | $32 | $24 | $27 | $20.62 | 30.94% |
| 2022-11-21 | 4 | $27 | $24 | $25.333 | $20.62 | 22.86% |
| 2022-12-07 | 4 | $27 | $25 | $26.333 | $20.62 | 27.71% |
| 2022-12-12 | 4 | $54 | $25 | $35.333 | $20.62 | 71.35% |
| 2023-05-16 | 5 | $54 | $25 | $35.5 | $20.62 | 72.16% |
| 2023-05-17 | 5 | $50 | $25 | $34.5 | $20.62 | 67.31% |
| 2023-08-14 | 5 | $50 | $22 | $33.75 | $20.62 | 63.68% |
| 2023-11-14 | 5 | $48 | $21 | $33 | $20.62 | 60.04% |
| 2023-12-08 | 6 | $48 | $21 | $35 | $20.62 | 69.74% |
The Trend in the Analyst Price Target
AVTE's average price target has moved up $12.33 over the prior 19 months.
AVTE reports an average of 107.28% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-16 | 5 | 54 | 25 | 35.50 | 19.51 | 81.96% |
| 2023-05-17 | 5 | 50 | 25 | 34.50 | 19.46 | 77.29% |
| 2023-08-14 | 5 | 50 | 22 | 33.75 | 14.95 | 125.75% |
| 2023-08-15 | 5 | 48 | 22 | 33.25 | 14.78 | 124.97% |
| 2023-11-14 | 5 | 48 | 22 | 33.25 | 14.15 | 134.98% |
AVTE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
AVTE's average broker recommendation rating improved by 0.17 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how AEROVATE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 320.76% of that group.
- AVTE has a lower variance in analysts' estimates than -941.24% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, AEROVATE THERAPEUTICS INC's average analyst price target is higher than 1477.88% of them.
- In terms of how AEROVATE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 630.77% of that group.
In the Pharmaceutical Products industry, RLYB, IMRX, and RANI are the three stocks most similar to AEROVATE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding AVTE using the data that counts. Try POWR Ratings for free.